A Behind-The-Counter Class Of Drugs Could Accelerate Rx-To-OTC Switches In U.S.

The switching of two products from prescription-only (Rx) to over-the-counter last year hinted that there may be a wave of similar switches on the horizon, and ones in therapeutic categories previously off limits to OTC availability. But without more products accessible without a prescription behind-the-counter, as opposed to off-the-shelf, such switches in the U.S. will continue to be limited in number.